跳至主要内容
临床试验/NCT00214032
NCT00214032已完成2 期

Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2002年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
2
试验地点
1
主要终点
reduction of arm lymphedema

研究概览

简要总结

The objectives of this study are to evaluate the effectiveness of Pycnogenol (French maritime pine bark extract) for arm lymphedema in women following treatment for breast cancer, to evaluate the accuracy and sensitivity of bioelectric impedence as a measurement of lymphedema of the arm, and to validate the proposed arm lymphedema quality-of-life questionnaire.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • > 6 months from last surgical and/or radiation treatment to the affected axilla
  • Unilateral lymphedema of the upper extremity

排除标准

  • May not be receiving or be scheduled to receive cytotoxic or radiation chemotherapy treatment while on this study

研究组 & 干预措施

1

Experimental

pycnogenol daily

干预措施: Pycnogenol (Drug)

2

Placebo Comparator

placebo daily

干预措施: Placebo (Drug)

结局指标

主要结局

reduction of arm lymphedema

时间窗: monthly

次要结局

  • comparison/validation of bioelectric impedance to measure lymphedema changes, validation of lymphedema questionnaire(monthly)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验